Skip to Main Content

Paper Details

A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells.
Cell Chem Biol
21
2022
8p11-p12 amplicon, BI-9321, Cas9, E3 ligase, MS9715, NSD3, NSD3's, NSD3-dependent hematological cancer cells, Nuclear receptor binding SET domain protein 3, PWWP1, PWWP1 domain, VHL, cMyc, cancer, cancer cells, cancers, human, oncogenic, tumor, tumor cells
Author NameAffiliation
Ricky D EdmondsonUniversity of Arkansas for Medical Sciences
Samuel G MackintoshUniversity of Arkansas for Medical Sciences
Jian JinMount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 3

Datasets

Release 1.2